Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
147 hedge funds and large institutions have $1.69B invested in Silk Road Medical, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 49 reducing their positions, and 9 closing their positions.
5,399% more call options, than puts
Call options by funds: $16.6M | Put options by funds: $302K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
89% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 9
26% more capital invested
Capital invested by funds: $1.34B → $1.69B (+$347M)
6% more funds holding
Funds holding: 139 → 147 (+8)
6% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 49
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$29.9M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$15.7M |
| 3 |
Jennison Associates
New York
|
+$10.1M |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$7.14M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$19.1M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$15.6M |
| 3 |
DM
Deerfield Management
New York
|
-$6.09M |
| 4 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
-$5.55M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$4.85M |
SILK Hedge Fund Activity: Q3 2022 in Review
147 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q3 2022, worth a combined $1.69B — up 26% from $1.34B a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new SILK positions and 9 closed out — a net gain of 8 holders — while 52 added to existing stakes and 49 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $29.9M. The largest seller was Wasatch Advisors, cutting an estimated $19.1M.
- 147 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q3 2022, up from 139 in Q2 2022.
- Funds reported $1.69B of Silk Road Medical, Inc. Common Stock stock for Q3 2022, up 26% quarter-over-quarter.
- 17 funds opened new Silk Road Medical, Inc. Common Stock positions in Q3 2022 and 9 closed out, a net change of +8 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q3 2022 was Janus Henderson Group, an estimated $29.9M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q3 2022 was Wasatch Advisors, an estimated $19.1M sold.
Based on aggregated 13F filings for Q3 2022.